Variant Upstream of IL12A in Autoimmune Disease Studies
A rare variant upstream of IL12A was found to significantly increase the risk of multiple sclerosis (MS), with an odds ratio of 1.79. Additionally, five out of six autoimmune diseases studied exhibited strong co-occurrence among themselves.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
This finding highlights a potential genetic factor that may influence susceptibility to MS and other autoimmune diseases, suggesting a shared pathogenic mechanism. Understanding these genetic links could inform future research and disease understanding.
What this does not prove
The study does not prove a direct causative link between IL12 pathway variants and MS, thus further investigation is necessary to establish any causative relationships.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-13
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceAutoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway. ↗DOI: 10.1097/hep.0000000000001819
Supporting passages (3)
publication date2026-10-13
findingsAPPROACH AND RESULTS: We identified a rare variant upstream of IL12A with large risk-increasing effects on autoimmune hepatitis [AIH; per-allele odds ratio (OR)=2.98, p=3×10-9], primary biliary cholangitis (PBC; OR=2.80, p=2×10-8), systemic sclerosis (SSc; OR=2.64, p=2×10-11), Sjogren's disease (SjD; OR=1.94, p=10-11), systemic lupus erythematosus (SLE; OR=1.83, p=5×10-10) and multiple sclerosis (OR=1.79, p=10-11).
limitationsTitle: Autoimmune hepatitis and primary biliary cholangitis are among a subset of autoimmune diseases defined by profound co-prevalence and genetic risk association with the IL12 pathway.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.